World Scientific Publishing Company, 2017. — 458 p.
This unique book deals with both inflammation and cancer in a single source of publication. They are seldom grouped together although it has been known that both diseases are closely associated, particularly in the gastrointestinal tract and liver. As the book touches on two such major areas of diseases in humans, it should be of interest to a wider audience of researchers and readers. It is noted that the book combines the effort of both basic scientists and clinicians from different countries with extensive experiences in molecular biology and clinical practice to unveil the most updated picture of the pathogenesis and therapeutic strategies in the treatment of inflammation and cancer in the digestive tract. In this regard, potential pathogenic modulators and also therapeutic options are widely discussed. These types of information would definitely broaden our knowledge in better understanding these diseases. Basic and clinical researchers in the fields of inflammation, hepatology, pathology, pharmacology, oncology and gastroenterology. Can be used as a reference for their research and clinical practice in academic and industrial sectors.
General Introduction to Inflammation and Cancer in the Digestive TractInflammation and Therapeutics in the Digestive TractBrain–Gut Relationship on Mucosal Inflammation in the Gastrointestinal Tract
Nesfatin-1: The Novel Appetite Peptide with Therapeutic Efficacy to Prevent Acute Hemorrhagic Gastric Lesions and Accelerate Gastric Ulcer Healing
Chemoprophylaxis in Inflammatory Bowel Diseases
Targeting the Nuclear Receptor HNF4α as a Potential Therapy for Gut Inflammation and Cancer
Established Therapies and New Therapeutic Strategies in Alcoholic Liver Disease
Carcinogenesis and Therapeutic Targets in the Gastrointestinal TractTargets of Tumor Epigenetics and Its Microenvironment in Gastrointestinal Cancer
Esophageal Cancer: From Bench to Bedside
Angiogenesis and Lymphangiogenesis in Gastric MALT Lymphoma: Relation of VEGF and VASH2
NF-κB as a Potential Molecular Target for Therapy of Gastrointestinal Cancers
Hypoxia-Inducible Factor-1α Modulation in Colorectal Carcinogenesis
Therapeutic Approaches Targeting the Serrated Pathway of Colorectal Cancer Characterized by Mutation in the BRAF Gene and Overexpression of GTPase Rac1b
The “Yin” and “Yang” of Target-Oriented Anticancer Phytochemicals Derived from Herbal Medicines
The Degradation System of Prostaglandin E2 in Gastrointestinal Cancer
Prostaglandin and Its Receptors: Potential Targets for Gastrointestinal Inflammation and Cancer
Autophagy and microRNAs as the Therapeutic Targets in Gastrointestinal CancersModulation of Autophagy as a Potential Therapeutic Target for Gastrointestinal Cancers: Promises and Uncertainties
microRNAs as Therapeutic Targets for Gastric Cancer
microRNA-based Novel Therapeutic Development in Gastrointestinal Cancer
Unraveling the Relationship between Autophagy and microRNA in Gastrointestinal Cancer